As a consequence, the overall survival in TC is good, since many cancerous processes with fast blood-derived spread (without nodule and goiter) were classified as lung cancer; noteworthy, this was with worse prognosis, since the BRAF mutation very specific for TC was classified as NSCLC, papillary type (see above). The gene discussed is BRAF; the disease is non-small cell lung carcinoma.